Patients at Monash Cancer Centre in Moorabbin will continue to access Peter Mac's state-of-the-art radiation therapy services after a new deal was signed with Monash Health this week.

This agreement gives patients access to our state-of-the-art radiation therapy closer to where they live.  

Peter Mac has been providing services at the Moorabin Hosptial for more than 20 years.

Peter Mac upgraded radiation therapy equipment at Moorabbin earlier this year and the centre now has two dedicated wide bore radiotherapy CT scanners and a state-of-the-art Varian TrueBeam linear accelerator, with another to come online next year.

“This equipment upgrade means we can provide more high precision radiation therapy to more patients,” Peter Mac Moorabbin Campus Manager Damien Phillips said. 

Patient Wendy from Sandringham joined a clinical trial combining stereotactic ablative body radiotherapy (SABR) at Peter Mac with an immunotherapy drug trial at Monash Cancer Centre.

SABR is a technique that delivers radiotherapy with pinpoint accuracy to each tumour site. 

 “Although I was treated at two separate institutions for the first stage of my therapy, the transition was seamless.” Wendy said. 

“I always felt confident with the experienced and caring staff who were treating me. It’s a great advantage having both hospitals near home.”

Peter Mac’s Moorabbin campus treats all cancer types including the highly complex head and neck, skin and sarcoma patients. 

From next year, the centre will also provide non-surgical, precisely-targeted radiation in fewer high-dose treatments to treat brain tumours known as stereotactic radiosurgery.